Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

Studies back Imatron's EBT (electron beam tomography) for heart conditions:

This article was originally published in Clinica

Executive Summary

Latest results from a trial of Imatron's electron beam tomography (EBT) scanner have backed previous findings which showed that the device could help evaluate emergency room patients with acute chest pain. The EBT coronary artery scan produced a negative predictive value of 100%, according to the new 134-patient study, published in the August edition of the American Journal Of Cardiology. The new data corroborates a similar study published in the Annals of Emergency Medicine (January), which showed that based on a negative scan, 800,000 patients could be safely discharged from emergency rooms in the US, said San Francisco, California-based Imatron.

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT079310

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel